News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MBL International Acquires Antibody Business From LifeSpan BioSciences, Inc.


2/14/2006 12:03:40 PM

Tokyo, Feb 14, 2006 (JCN) - Medical and Biological Laboratories (MBL) announced on February 13 that its Massachusetts-based subsidiary MBL International has acquired the antibody business of LifeSpan BioSciences (LifeSpan) of Seattle.

LifeSpan is a bio venture company that offers a wide range of antibodies, namely more than 900 types including 800 GPCR (G-protein coupled receptor) antibodies.

With this move, MBL International now has more than 4,000 antibody products. Accordingly, it will promote its sales initiatives in the global market.


Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES